161 related articles for article (PubMed ID: 37062410)
1. Systemic Reduction of Glut1 Normalizes Retinal Dysfunction, Inflammation, and Oxidative Stress in the Retina of Spontaneous Type 2 Diabetic Mice.
Aiello JJ; Bogart MC; Chan WT; Holoman NC; Trobenter TD; Relf CE; Kleinman DM; De Vivo DC; Samuels IS
Am J Pathol; 2023 Jul; 193(7):927-938. PubMed ID: 37062410
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
Holoman NC; Aiello JJ; Trobenter TD; Tarchick MJ; Kozlowski MR; Makowski ER; De Vivo DC; Singh C; Sears JE; Samuels IS
J Neurosci; 2021 Apr; 41(14):3275-3299. PubMed ID: 33622781
[TBL] [Abstract][Full Text] [Related]
3. Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes.
Samuels IS; Bell BA; Pereira A; Saxon J; Peachey NS
J Neurophysiol; 2015 Feb; 113(4):1085-99. PubMed ID: 25429122
[TBL] [Abstract][Full Text] [Related]
4. Suppression of diabetic retinopathy with GLUT1 siRNA.
You ZP; Zhang YL; Shi K; Shi L; Zhang YZ; Zhou Y; Wang CY
Sci Rep; 2017 Aug; 7(1):7437. PubMed ID: 28785055
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: Effect on glucose transporter-1 and GAP43 expression.
Mohammad HMF; Sami MM; Makary S; Toraih EA; Mohamed AO; El-Ghaiesh SH
Life Sci; 2019 Sep; 232():116588. PubMed ID: 31226418
[TBL] [Abstract][Full Text] [Related]
6.
Majimbi M; McLenachan S; Nesbit M; Chen FK; Lam V; Mamo J; Takechi R
Front Endocrinol (Lausanne); 2023; 14():1224418. PubMed ID: 37850093
[TBL] [Abstract][Full Text] [Related]
7. Endogenous insulin signaling in the RPE contributes to the maintenance of rod photoreceptor function in diabetes.
Tarchick MJ; Cutler AH; Trobenter TD; Kozlowski MR; Makowski ER; Holoman N; Shao J; Shen B; Anand-Apte B; Samuels IS
Exp Eye Res; 2019 Mar; 180():63-74. PubMed ID: 30543793
[TBL] [Abstract][Full Text] [Related]
8. Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
Solà-Adell C; Bogdanov P; Hernández C; Sampedro J; Valeri M; Garcia-Ramirez M; Pasquali C; Simó R
Curr Eye Res; 2017 Sep; 42(9):1273-1286. PubMed ID: 28574750
[TBL] [Abstract][Full Text] [Related]
9. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
[TBL] [Abstract][Full Text] [Related]
10. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
[TBL] [Abstract][Full Text] [Related]
11. Anti-diabetic potential of chromium histidinate in diabetic retinopathy rats.
Ulas M; Orhan C; Tuzcu M; Ozercan IH; Sahin N; Gencoglu H; Komorowski JR; Sahin K
BMC Complement Altern Med; 2015 Feb; 15():16. PubMed ID: 25652875
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
Li J; Wang JJ; Chen D; Mott R; Yu Q; Ma JX; Zhang SX
Exp Eye Res; 2009 Jun; 89(1):71-8. PubMed ID: 19254713
[TBL] [Abstract][Full Text] [Related]
13. Suppression of GLUT1; a new strategy to prevent diabetic complications.
Lu L; Seidel CP; Iwase T; Stevens RK; Gong YY; Wang X; Hackett SF; Campochiaro PA
J Cell Physiol; 2013 Feb; 228(2):251-7. PubMed ID: 22717959
[TBL] [Abstract][Full Text] [Related]
14. WNT-inhibitory factor 1-mediated glycolysis protects photoreceptor cells in diabetic retinopathy.
Chen B; Zou J; Xie L; Cai Y; Li B; Tan W; Huang J; Li F; Xu H
J Transl Med; 2024 Mar; 22(1):245. PubMed ID: 38448948
[TBL] [Abstract][Full Text] [Related]
15. Montelukast Prevents Early Diabetic Retinopathy in Mice.
Bapputty R; Talahalli R; Zarini S; Samuels I; Murphy R; Gubitosi-Klug R
Diabetes; 2019 Oct; 68(10):2004-2015. PubMed ID: 31350303
[TBL] [Abstract][Full Text] [Related]
16. GLUT1 activity contributes to the impairment of PEDF secretion by the RPE.
Calado SM; Alves LS; Simão S; Silva GA
Mol Vis; 2016; 22():761-70. PubMed ID: 27440994
[TBL] [Abstract][Full Text] [Related]
17. Diabetes Alters Diurnal Rhythm of Electroretinogram in db/db Mice.
Di R; Luo Q; Mathew D; Bhatwadekar AD
Yale J Biol Med; 2019 Jun; 92(2):155-167. PubMed ID: 31249476
[TBL] [Abstract][Full Text] [Related]
18. Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease.
Samuels IS; Lee CA; Petrash JM; Peachey NS; Kern TS
Vis Neurosci; 2012 Nov; 29(6):267-74. PubMed ID: 23101909
[TBL] [Abstract][Full Text] [Related]
19. Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice.
Bogdanov P; Solà-Adell C; Hernández C; García-Ramírez M; Sampedro J; Simó-Servat O; Valeri M; Pasquali C; Simó R
J Diabetes Complications; 2017 Oct; 31(10):1481-1490. PubMed ID: 28847447
[TBL] [Abstract][Full Text] [Related]
20. Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1.
Ha Y; Saul A; Tawfik A; Zorrilla EP; Ganapathy V; Smith SB
Mol Vis; 2012; 18():2860-70. PubMed ID: 23233788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
